News
11h
The Desk on MSNLionsgate shareholders approve split from StarzLionsgate has received shareholder approval to separate its studio and Starz businesses, creating two independent publicly ...
The Starz split comes after Lionsgate launched the publicly-traded Lionsgate Studios via a SPAC deal with Screaming Eagle ...
Lionsgate Studios, Starz Split Approved By Shareholders, Key Hurdle For Long Anticipated Transaction
Lionsgate shareholders approved the separation of the studio business and Starz, clearing a key hurdle in the long ...
The 'John Wick' and 'Hunger Games' studio got overwhelmingly support from investors for a full separation to create two ...
Jared Bossly was planting soybeans one spring night in 2023 on his 2,000-acre farm in South Dakota when he spotted a sheriff’s vehicle parked at the corner of his property. He had a hunch it ...
Bruce Tobey has signed a new multiyear agreement with Lionsgate to continue as executive vp and general counsel through March 2028. In a regulatory filing on Thursday, Lionsgate disclosed that as ...
Mika Brzezinski recaps this year’s 30/50 Summit, which brought together nearly 500 women from 46 different countries to network, connect and celebrate International Women’s Day.April 10 ...
By Etan Vlessing Canada Bureau Chief Bruce Tobey has signed a new multiyear agreement with Lionsgate to continue as executive vp and general counsel through March 2028. In a regulatory filing on ...
The Survival read-out on the Summit Therapeutics (SMMT)’ HARMONi-2 study is one of the most anticipated biotech datapoints this year, and Truist tells investors in a research note that its ...
American shipyards will again be absent from a key annual summit for the global shipbuilding industry, in the latest sign that the United States is charting a lonely course as it strives to revive ...
For its third year, the Black Women in Food Summit is celebrating the talent, resilience and innovation of Black women in the food industry by bringing together renowned chefs and restaurateurs ...
Truist Financial analyst Asthika Goonewardene maintained a Buy rating on Summit Therapeutics (SMMT – Research Report) today. The company’s shares closed yesterday at $18.23. Discover ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results